官方服务：
资源简介：
Time to onset of acne in a post hoc analysis of 3 placebo-controlled phase 3 trials of upadacitinib in patients with atopic dermatitis
应用场景：
创建时间：
2022-07-13
相关数据集
Risk Factors in Atopic Dermatitis for the Development of Eczema Herpeticum (ADEH 06)
Atopic Dermatitis (AD), also known as eczema, is a skin disease that causes the skin to be hot, dry and scaly, and have severe itching. There are different kinds of eczema. Eczema herpeticum (EH) is a
DataCite Commons2022-12-21 更新140
Emerging nanotechnology backed formulations for the management of atopic dermatitis
Supplementary table 1
DataCite Commons2024-05-17 更新100
Supplementary Material for: Use of Complementary and Alternative Therapies in Outpatients with Atopic Dermatitis from a Dermatological University Department
Background: Treatment of atopic dermatitis (AD) may be challenging, therefore some patients seek complementary and alternative medications (CAM). We determined prevalence and predictors
DataCite Commons2020-08-27 更新60
A Phase 2 Randomized Trial of Apremilast in Patients With Atopic Dermatitis. A Phase 2 Randomized Trial of Apremilast in Patients With Atopic Dermatitis
A phase 2, double-blind, placebo-controlled trial evaluated apremilast efficacy, safety, and pharmacodynamics in adults with moderate to severe atopic dermatitis (AD). Overall design: Patients were ra
NIAID Data Ecosystem130
Additional file 6: of Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis
Table S3. A full list of principal molecular and cellular functions associated with upstream regulators expressed in interferon-gamma (IFN-Îł)-primed Whartonâ s jelly-derived mesenchymal stem cells (W
Mendeley Data2024-06-29 更新100
